Cargando…

Polycystic ovary syndrome and circulating inflammatory markers

BACKGROUND: Human and experimental studies suggest that the sympathetic regulatory drive in the ovary may be unbalanced (hyperactivity) in polycystic ovary syndrome (PCOS). Dysfunctional secretion of interleukin (IL) -1 (α & β) or related cytokines may thus be related to abnormal ovulation and l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zafari Zangeneh, Farideh, Naghizadeh, Mohammad Mehdi, Masoumi, Masoumeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research and Clinical Center for Infertility 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605859/ https://www.ncbi.nlm.nih.gov/pubmed/29177240

Ejemplares similares

Psychological Distress in Women with Polycystic Ovary Syndrome from Imam Khomeini Hospital, Tehran
por: Zangeneh, Farideh Zafari, et al.
Publicado: (2012)

Effect of Ramadan Fasting on Stress Neurohormones in Women with Polycystic Ovary Syndrome
por: Zangeneh, Farideh, et al.
Publicado: (2015)

Deregulated Brain’s Central Clock Management on Sleep-Wake Behavior in Women With Polycystic Ovary Syndrome: Melatonin & Sleep Pattern
por: Zafari Zangeneh, Farideh
Publicado: (2022)

Effects of Chamomile Extract on Biochemical and Clinical Parameters in a Rat Model of Polycystic Ovary Syndrome
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2010)

Locus coeruleus lesions and PCOS: role of the central and peripheral sympathetic nervous system in the ovarian function of rat
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2012)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
por: Rudnicka, E., et al.
Publicado: (2020)

Investigation Trp64Arg polymorphism of the beta 3-adrenergic receptor gene in nonobese women with polycystic ovarian syndrome
por: Zangeneh, Farideh Zafari, et al.
Publicado: (2020)

Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System
por: Zafari Zangeneh, Farideh
Publicado: (2022)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome
por: Rahiminejad, Mohammad Ehsan, et al.
Publicado: (2014)

Major determinants of circulating myostatin in polycystic ovary syndrome
por: Arpaci, Haldun
Publicado: (2019)

Study of early atherosclerotic markers in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2012)

The physiological basis with uterine myometrium contractions from electro-mechanical/hormonal myofibril function to the term and preterm labor
por: Zangeneh, Farideh Zafari, et al.
Publicado: (2023)

Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review
por: Mohammadi, Masoumeh
Publicado: (2019)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Circulating SCUBE1 levels in women with polycystic ovary syndrome
por: Erol, Onur, et al.
Publicado: (2018)

Estradiol and COVID-19: Does 17-Estradiol Have an Immune-Protective Function in Women Against Coronavirus?
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2021)

Differences in and Correlates of Sexual Function in Infertile Women with and without Polycystic Ovary Syndrome
por: Akbari Sene, Azadeh, et al.
Publicado: (2021)

Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome
por: Maidana, P., et al.
Publicado: (2019)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome
por: Borzoei, Azam, et al.
Publicado: (2017)

Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
por: Agacayak, Elif, et al.
Publicado: (2015)

Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
por: Enjezab, Behnaz, et al.
Publicado: (2017)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome
por: Zhou, Hong, et al.
Publicado: (2022)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Cutaneous manifestation of polycystic ovary syndrome
por: Abusailik, Mohammad A., et al.
Publicado: (2021)

Hyperprolactinemia and Hirsutism in Patients Without Polycystic Ovary Syndrome
por: Tirgar-Tabari, Soudabeh, et al.
Publicado: (2016)

Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome
por: Hosseinkhani, Ayda, et al.
Publicado: (2017)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome
por: Salama, Amany Alsayed, et al.
Publicado: (2015)

Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18
Publicado: (2022)

Circulating Vascular Progenitor Cells and Central Arterial Stiffness in Polycystic Ovary Syndrome
por: Dessapt-Baradez, Cecile, et al.
Publicado: (2011)

Effect of chamomile capsule on lipid- and hormonal-related parameters among women of reproductive age with polycystic ovary syndrome
por: Heidary, Maryam, et al.
Publicado: (2018)

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
por: Abdalqader, Manal Madany, et al.
Publicado: (2020)

Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome
por: Wide, Leif, et al.
Publicado: (2021)

Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management
por: Davoudi, Zahra, et al.
Publicado: (2021)

Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass Index
por: Samy, Nervana, et al.
Publicado: (2009)

Serum Leptin Level in Women with Polycystic Ovary Syndrome: Correlation with Adiposity, Insulin, and Circulating Testosterone
por: Chakrabarti, J
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pv4hhcv9u10in852lph3k0fk6q